Hypertension risk in Dutch women with symptomatic uterine fibroids

American Journal of Hypertension

Volumn 28, Issue 4, 2015, Pages 487-492

  Haan, Yentl C ^a   Oudman, Inge ^a   De Lange, Maria E ^a   Timmermans, Anne ^a   Ankum, Willem M ^a   Montfrans, Gert A Van ^a   Brewster, Lizzy M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

African ancestry; blood pressure; creatine kinase; growth factors; hypertension; leiomyoma uteri

Indexed keywords

ADULT; AFRICAN; AGE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE CUFF; BLOOD PRESSURE METER; BODY MASS; CANCER SURGERY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DUTCHMAN; FEMALE; GYNECOLOGIC SURGERY; HUMAN; HYPERTENSION; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; NON INVASIVE BLOOD PRESSURE MONITOR; PREVALENCE; PRIORITY JOURNAL; UTERUS MYOMA; CASE CONTROL STUDY; LEIOMYOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; ODDS RATIO; PATHOPHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; UTERINE NEOPLASMS;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; LEIOMYOMA; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NETHERLANDS; ODDS RATIO; RISK FACTORS; SEX FACTORS; UTERINE NEOPLASMS;

EID: 84938538365     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpu183     Document Type: Article

References (36)

1. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Pina HL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CL, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC, Sopko G Jr, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation 2011; 123:1243-1262.
2. Papakonstantinou NA, Stamou MI, Baikoussis NG, Goudevenos J, Apostolakis E. Sex differentiation with regard to coronary artery disease. J Cardiol 2013; 62:4-11.
3. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER III, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014; 129:e28-e292.
4. Faerstein E, Szklo M, Rosenshein NB. Risk factors for uterine leiomyoma: a practice-based case-control study. II. Atherogenic risk factors and potential sources of uterine irritation. Am J Epidemiol 2001; 153:11-19.
5. Parazzini F, Chiaffarino F, Polverino G, Chiantera V, Surace M, La Vecchia C. Uterine fibroids risk and history of selected medical conditions linked with female hormones. Eur J Epidemiol 2004; 19:249-253.
6. Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer SA, Wright R. A prospective study f hypertension and risk of uterine leiomyomata. Am J Epidemiol 2005; 161:628-638.
7. Takeda T, Sakata M, Isobe A, Miyake A, Nishimoto F, Ota Y, Kamiura S, Kimura T. Relationship between metabolic syndrome and uterine leiomyomas: a case-control study. Gynecol Obstet Invest 2008; 66:14-17.
8. Radin RG, Rosenberg L, Palmer JR, Cozier YC, Kumanyika SK, Wise LA. Hypertension and risk of uterine leiomyomata in US black women. Hum Reprod 2012; 27:1504-1509.
9. Sivri N, Yalta T, Say?n C, Yalta K, Ozpuyan F, Ta?tekin E, Yetkin E. Evaluation of cardiovascular risk factors in women with uterine leimyoma: is there a link with atherosclerosis? Balkan Med J 2012; 29:320-323.
10. Aksoy Y, Sivri N, Karaoz B, Say?n C, Yetkin E. Carotid intima-media thickness: a new marker of patients with uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol 2014; 175:54-57.
11. Lambertino A, Turyk M, Anderson H, Freels S, Persky V. Uterine leiomyomata in a cohort of Great Lakes sport fish consumers. Environ Res 2011; 111:565-572.
12. Sadlonova J, Kostal M, Smahelova A, Hendl J, Starkova J, Nachtigal P. Selected metabolic parameters and the risk for uterine fibroids. Int J Gynaecol Obstet 2008; 102:50-54.
13. Luoto R, Kaprio J, Reunanen A, Rutanen EM. Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol 1995; 85:515-522.
14. Luoto R, Rutanen EM, Auvinen A. Fibroids and hypertension. A crosssectional study of women undergoing hysterectomy. J Reprod Med 2001; 46:359-564.
15. Spies JB, Bradley LD, Guido R, Maxwell GL, Levine BA, Coyne K. Outcomes from leiomyoma therapies: comparison with normal controls. Obstet Gynecol 2010; 116:641-652.
16. Silver MA, Raghuvir R, Fedirko B, Elser D. Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling. J Clin Hypertens 2005; 7:664-668.
17. Brewster LM, Mairuhu G, Bindraban NR, Koopmans RP, Clark JF, van Montfrans GA. Creatine kinase activity is associated with blood pressure. Circulation 2006; 114:2034-2039.
18. Ciarmela P, Islam MS, Reis FM, Gray PC, Bloise E, Petraglia F, Vale W, Castellucci M. Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update 2011; 17:772-790.
19. Li Y, Levesque LO, Anand-Srivastava MB. Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR. Am J Physiol Heart Circ Physiol 2010; 299:H1959-H1967.
20. Eude I, Dallot E, Vacher-Lavenu MC, Chapron C, Ferre F, Breuiller-Fouche M. Potentiation response of cultured human uterine leiomyoma cells to various growth factors by endothelin-1: role of protein kinase C. Eur J Endocrinol 2001; 144:543-548.
21. Isobe A, Takeda T, Sakata M, Miyake A, Yamamoto T, Minekawa R, Nishimoto F, Okamoto Y, Walker CL, Kimura T. Dual repressive effect of angiotensin II-type 1 receptor blocker telmisartan on angiotensin II-induced and estradiol-induced uterine leiomyoma cell proliferation. Hum Reprod 2008; 23:440-446.
22. Bouallegue A, Vardatsikos G, Srivastava AK. Involvement of insulinlike growth factor 1 receptor transactivation in endothelin-1-induced signaling in vascular smooth muscle cells. Can J Physiol Pharmacol 2010; 88:501-509.
23. Kimura C, Konishi S, Hasegawa M, Oike M. Development of vascular smooth muscle contractility by endothelium-derived transforming growth factor ? proteins. Pflugers Arch 2014; 466:369-380.
24. Batenburg WW, Jansen PM, van den Bogaerdt AJ, J Danser AH. Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase. Cardiovasc Res 2012; 94:136-43.
25. Batchu SN, Korshunov VA. Novel tyrosine kinase signaling pathways: implications in vascular remodeling. Curr Opin Nephrol Hypertens 2012; 21:122-7.
26. Brewster LM, Clark JF, van Montfrans GA. Is greater tissue activity of creatine kinase the genetic factor increasing hypertension risk in black people of sub-Saharan African descent? J Hypertens 2000; 18:1537-1544.
27. Somjen D, Knoll E, Kohen F, Stern N. Effects of phytoestrogens on DNA synthesis and creatine kinase activity in vascular cells. Am J Hypertens 2001; 14:1256-1262.
28. Somjen D, Kohen F, Jaffe A, Amir-Zaltsman Y, Knoll E, Stern N. Effects of gonadal steroids and their antagonists on DNA synthesis in human vascular cells. Hypertension 1998; 32:39-45.
29. Brewster LM, Coronel CM, Sluiter W, Clark JF, van Montfrans GA. Ethnic differences in tissue creatine kinase activity: an observational study. PLoS One 2012; 7:e32471.
30. Salvadori A, Fanari P, Ruga S, Brunani A, Longhini E. Creatine kinase and creatine kinase-MB isoenzyme during and after exercise testing in normal and obese young people. Chest 1992; 102:1687-1689.
31. Hoag GN, Franks CR, Smith C, DeCoteau WE. Creatine kinase isoenzyme patterns in normal smooth muscle and smooth muscle neoplasms. Clin Biochem 1980; 13:149-150.
32. Brewster LM, Taherzadeh Z, Volger S, Clark JF, Rolf T, Wolf H, VanBavel E, van Montfrans GA. Ethnic differences in resistance artery contractility of normotensive pregnant women. Am J Physiol Heart Circ Physiol 2010; 299:H431-H436.
33. Moss NS, Benditt EP. Human atherosclerotic plaque cells and leiomyoma cells. Comparison of in vitro growth characteristics. Am J Pathol 1975; 78:175-190.
34. Stewart EA, Nowak RA. New concepts in the treatment of uterine leiomyomas. Obstet Gynecol 1998; 92:624-627.
35. Ganten D, Schelling P, Vecsei P, Ganten U. Iso-renin of extrarenal origin. "The tissue angiotensinogenase systems". Am J Med 1976; 60:760-772.
36. Handler J, Zhao Y, Egan BM. Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999-2008. J Clin Hypertens (Greenwich) 2012;14:751-9.